InvestorsHub Logo
Followers 27
Posts 620
Boards Moderated 0
Alias Born 11/22/2014

Re: None

Thursday, 05/28/2015 10:26:12 PM

Thursday, May 28, 2015 10:26:12 PM

Post# of 690221
My thoughts on short interest is its coming from the large pharma companies funneled through hedge funds. If you think about the economics the cost of shorting NWBO is minimal compared to their gains.
By keeping nwbo off the radar other technologies look good and their valuations are high. Also there have been 2 or 3? Approvals of immuno products by big pharma that show questionable efficacy. This alone is worth billions.
The end of the game is coming soon though if we have the data for L and Direct, which I believe we do.
And now that we have solid European backing via government and investment funds this makes the likelihood of success much more compelling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News